Stay updated on Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page
- Check4 days agoChange DetectedPage revision label updated from v3.5.4 to v3.5.5, indicating a minor revision of the document. This change signals a version bump and does not modify the stated study details or eligibility information.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedSponsor for the MOR106 study is updated, switching the listed sponsor from Galapagos NV to Lakefront Biotherapeutics NV.SummaryDifference0.2%

- Check25 days agoChange DetectedThe page shows Revision: v3.5.4 instead of v3.5.3, representing a minor version update. This update does not modify the visible content or functionality of the page.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page revision label has been incremented from v3.5.2 to v3.5.3, indicating a minor technical update without changing the displayed study details.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check83 days agoChange DetectedAn addition: Revision: v3.5.0. A deletion: Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.